Literature DB >> 24042971

Prevalence of tobacco use among adults in Egypt, 2009.

Heba Fouad1, Fatimah El Awa2, Randa Abou El Naga2, Awatef Hussien Emam3, Sahar Labib4, Krishna Mohan Palipudi5, Linda J Andes5, Samira Asma5, Brandon Talley6.   

Abstract

INTRODUCTION: We assessed the differences in overall use of tobacco and in the use of various tobacco products, by sex and by frequency of use across various demographic groups.
METHODS: We used data from the Global Adult Tobacco Survey (GATS), conducted in 2009 in Egypt. The data consist of answers to GATS by 20,924 respondents from a nationally representative, multistage probability sample of adults aged 15 years or older from all regions of Egypt. Current tobacco use was defined as current smoking or use of smokeless tobacco products, either daily or occasionally. We analyzed the differences in current cigarette, shisha, and smokeless tobacco use by sex and frequency of use (daily or occasional); and by demographic characteristics that included age, region, education level and employment status.
RESULTS: Overall, 19.7% of the Egyptian population currently use some form of tobacco. Men (38.1% [95% confidence interval (CI) 36.8-39.4]) are much more likely than women (0.6% [95% CI 0.4-0.9]) to use tobacco. Almost 96% of men who use tobacco, do so daily. Men are more likely to use manufactured cigarettes (31.8% [95% CI 30.6-33.1]) than shisha (6.2% [95% CI 5.6-6.9]) or smokeless tobacco (4.1% [95% CI 3.4-4.8]). Few women use tobacco (cigarettes (0.2%), shisha (0.3%) and smokeless tobacco (0.3%)); however, all women who currently smoke shisha, do so daily. Lower educational status, being between ages 25-64 and being employed predicted a higher use of tobacco.
CONCLUSION: Egypt has implemented several initiatives to reduce tobacco use. The World Health Organization (WHO) MPOWER technical package, which aims to reverse the tobacco epidemic, is implemented at various levels throughout the country. Our findings show that there is significant variation in the prevalence of tobacco use and types of tobacco used by adult men and women in Egypt. GATS data can be used to better understand comparative patterns of tobacco use by adults, which in turn can be used to develop interventions.
© The Author(s) 2013.

Entities:  

Keywords:  Egypt; Global Adult Tobacco Survey; World Health Organization; epidemiology; gender differences; shisha; smoking; tobacco; tobacco addiction; tobacco reduction plan

Mesh:

Year:  2013        PMID: 24042971     DOI: 10.1177/1757975913499801

Source DB:  PubMed          Journal:  Glob Health Promot        ISSN: 1757-9759


  5 in total

1.  Waterpipe tobacco smoking: A new smoking epidemic among the young?

Authors:  Eric K Soule; Thokozeni Lipato; Thomas Eissenberg
Journal:  Curr Pulmonol Rep       Date:  2015-09-04

2.  Tobacco consumption in the Kingdom of Saudi Arabia, 2013: findings from a national survey.

Authors:  Maziar Moradi-Lakeh; Charbel El Bcheraoui; Marwa Tuffaha; Farah Daoud; Mohammad Al Saeedi; Mohammed Basulaiman; Ziad A Memish; Mohammad A AlMazroa; Abdullah A Al Rabeeah; Ali H Mokdad
Journal:  BMC Public Health       Date:  2015-07-05       Impact factor: 3.295

3.  The impact of local smoke-free policies on smoking behaviour among adults in Indonesia: a quasi-experimental national study.

Authors:  Wahyu Septiono; Mirte A G Kuipers; Nawi Ng; Anton E Kunst
Journal:  Addiction       Date:  2020-05-27       Impact factor: 6.526

4.  Application of the Abridged SimSmoke model to four Eastern Mediterranean countries.

Authors:  David T Levy; Heba Fouad; Jeffrey Levy; Anca D Dragomir; Fatima El Awa
Journal:  Tob Control       Date:  2015-06-16       Impact factor: 7.552

5.  Incidence and etiology of hospitalized acute respiratory infections in the Egyptian Delta.

Authors:  Emily Rowlinson; Erica Dueger; Adel Mansour; Nahed Azzazy; Hoda Mansour; Lisa Peters; Summer Rosenstock; Sarah Hamid; Mayar M Said; Mohamed Geneidy; Monier Abd Allah; Amr Kandeel
Journal:  Influenza Other Respir Viruses       Date:  2016-08-12       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.